Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence.

Saved in:
Bibliographic Details
Title: Plasma Metabolome Signature Indicative of BRCA1 Germline Status Independent of Cancer Incidence.
Authors: Penkert J; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Märtens A; Department of Bioinformatics and Biochemistry, Braunschweig Integrated Center of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany., Seifert M; Connexome Consulting, Fischen, Germany., Auber B; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Derlin K; Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany., Hille-Betz U; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany., Hörmann P; Department of Bioinformatics and Biochemistry, Braunschweig Integrated Center of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany., Klopp N; Hannover Unified Biobank (HUB), Hannover, Germany., Prokein J; Center for Information Management, Hannover Medical School, Hannover, Germany., Schlicker L; Division of Tumour Metabolism and Microenvironment, German Cancer Research Center (DKFZ), Heidelberg, Germany., Wacker F; Department of Diagnostic and Interventional Radiology, Hannover Medical School, Hannover, Germany., Wallaschek H; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Schlegelberger B; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Hiller K; Department of Bioinformatics and Biochemistry, Braunschweig Integrated Center of Systems Biology (BRICS), Technische Universität Braunschweig, Braunschweig, Germany.; Computational Biology of Infection Research, Helmholtz Centre for Infection Research, Braunschweig, Germany., Ripperger T; Department of Human Genetics, Hannover Medical School, Hannover, Germany., Illig T; Department of Human Genetics, Hannover Medical School, Hannover, Germany.; Hannover Unified Biobank (HUB), Hannover, Germany.
Source: Frontiers in oncology [Front Oncol] 2021 Apr 07; Vol. 11, pp. 627217. Date of Electronic Publication: 2021 Apr 07 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2021.627217